Project Description

Developing an innovative and programmable virus-inspired particle (ViP) platform that can be used as a delivery system to target and treat numerous diseases.

Verimmune is currently using the ViPs to develop a first-in-class cancer therapy called Anti-tumor Immune Redirection (AIR) which redirects pre-existing memory T-cells from past infections to target cancers for destruction.